Back to search results

A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingPHASE1

Conditions

Advanced Solid Tumor

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • HonorHealth Research Institiute, Scottsdale, Arizona, United States

    Contact: Study coordinator (Oncology Nurse Navigator) · clinicaltrials@honorhealth.com · 480-323-1364
    Contact: Principal Investigator (Erkut Borazanci, MD)

  • Stanford Cancer Center, Palo Alto, California, United States

  • Carolina BioOncology Institute, Huntersville, North Carolina, United States

  • Abramson Cancer Center at Pennsylvania Hospital, Philadelphia, Pennsylvania, United States

  • Rhode Island Hospital, Providence, Rhode Island, United States

    Contact: Study coordinator (Stephan Sando) · ssando@brownhealth.org · 401-606-6602
    Contact: Principal Investigator (Howard Safran, MD)

  • Mary Crowley Cancer Research, Dallas, Texas, United States

  • Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Susan Sharry, CCRP) · susan.sharry@hci.utah.edu · 801-587-4488
    Contact: Principal Investigator (Vaia Florou, MD)

  • NEXT Virginia, Fairfax, Virginia, United States

    Contact: Study coordinator (Malaika Komtangi) · mkomtangi@nextoncology.com · 210-580-9500
    Contact: Principal Investigator (Alexander Spira, MD, PhD, FACP)
View source on ClinicalTrials.gov(opens in a new tab)